HealthBanks Celebrates Highly-Anticipated Launch with Giveaways, Including Free Immune Cell Storage for Life
IRVINE, Calif. (Dec. 15, 2020) – HealthBanks Biotech, Inc. (the “HealthBanks”), a technological leader in the stem cell banking industry, today introduced the first-of-its-kind, GMP-compliant immune cell banking service for future use in immunotherapies. In the fight...
Cord blood is blood that is found in the blood vessels of the placenta and umbilical cord. It is typically collected immediately after birth—right after the baby’s cord is cut. As a procedure, it is generally safe for both mom and baby. The tricky part is in the...
Immune Cell Banking News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Cord Blood Banking News
Stem Cells Banks and Stem Cells Banking are sure to play a critical role in the future of medicine. If you are unsure what stem cells banks are, or if you are simply looking for more information about stem cells banking in general, then you have come to the right...
Umbilical cord blood is an easily accessible blood source that can be retrieved shortly after a new baby is welcomed to the world. This non-invasive procedure and umbilical cord blood banking have significant implications for medical research, and for your own...
Subscribe to Our Newsletter & Special Promotions
Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.
HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.
*Price Match is based on the same technology and service scope.